overview of recent changes to the treatment landscape for her2-positive crc
Published 10 days ago • 42 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
0:43
how will the mountaineer trial affect the her2-positive mcrc treatment landscape?
-
1:08
targeting her2 in colorectal cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
0:38
current biomarker testing guidelines for colorectal cancer
-
24:05
2021 force | hereditary cancer | what's new in colorectal cancer treatment?
-
1:03:11
new advances in crc treatments: a global overview
-
55:33
colorectal cancer: what's new & what’s on the horizon?
-
3:17
genomic and transcriptomic characterization of small bowel adenocarcinoma
-
17:14
colon cancer: a comprehensive overview (illustrative tutorial by oster oncology)
-
3:46
outcomes from adapt-hr-/her2 evaluating dual her2 blockade
-
1:22
influence of sidedness on prognosis and treatment in mcrc
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
16:01
osler colorectal surgery online review 2023
-
2:23
the impact of her2 amplification in colorectal cancer
-
0:44
what is a her2 tumor?
-
2:31
cancer care together: chapters health system & moffitt cancer center
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
35:37
overview - management of advanced colorectal cancer
-
0:55
molecular testing for the evaluation of colorectal cancer
-
4:16
the role of the trop2 biomarker in cancer